Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Inhibition of CDK Activity

Inhibition of CDK Activity

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Research Training of Future Leaders in Radiology: A Pilot International Outreach Educational Program.

Cureus·2026

Same author

Real-world treatment patterns for metastatic urothelial cancer in 5 European countries: EVEREST 2.

Future oncology (London, England)·2026

Same author

Impact of a factor Xa inhibitor (apixaban) on SIV pathogenesis and response to antiretroviral therapy.

JCI insight·2026

Same author

Assessment of visual contrast sensitivity in biotoxin-exposed individuals using four testing methods.

Annals of medicine·2026

Same author

A novel RNA nucleic acid amplification test more accurately distinguishes active <i>Clostridioides difficile</i> infection from colonization.

medRxiv : the preprint server for health sciences·2026

Same author

Barriers and Facilitators of Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer.

JAMA network open·2025

Same journal

Allergic Contact Dermatitis Caused by Online-Purchased Black Henna Temporary Tattoos.

The Australasian journal of dermatology·2026

Same journal

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026

Same journal

Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era.

The Australasian journal of dermatology·2026

Same journal

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series.

The Australasian journal of dermatology·2026

Same journal

The Dermatologist's Role in Early PMOS Diagnosis.

The Australasian journal of dermatology·2026

Same journal

From Curriculum Variation to Clinical Capability: Advancing Dermatology Education in Australia.

The Australasian journal of dermatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 26, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Cyclophosphamide in dermatology.

Janet Kim¹, Jonathan J Chan¹

¹Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

The Australasian Journal of Dermatology

|January 26, 2016

Summary

This summary is machine-generated.

Cyclophosphamide is an effective immunosuppressive drug for autoimmune diseases. While its use in dermatology is limited, pulsed intravenous regimens may reduce toxicity, offering a potential treatment option for severe skin conditions.

Keywords:

cutaneous cyclophosphamide dermatology i.v.pulsed side-effect

More Related Videos

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Related Experiment Videos

Last Updated: Mar 26, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Area of Science:

Immunology
Dermatology
Pharmacology

Background:

Cyclophosphamide is a chemotherapy drug with potent immunosuppressive properties.
It is widely used for malignancies and severe autoimmune diseases.
Pulsed intravenous regimens reduce toxicity compared to oral or high-dose chemotherapy.

Purpose of the Study:

To review the current literature on cyclophosphamide.
To explore its clinical applications in dermatology.
To highlight its potential as an underutilized treatment modality.

Main Methods:

Literature review of clinical applications of cyclophosphamide.
Analysis of efficacy and toxicity profiles in various medical fields.
Focus on dermatological studies and case reports.

Main Results:

Cyclophosphamide demonstrates significant efficacy in treating severe autoimmune conditions.
Pulsed i.v. regimens are associated with lower adverse effects in rheumatology.
Dermatological applications remain relatively underused despite its immunosuppressive potential.

Conclusions:

Cyclophosphamide is a viable, potent immunosuppressive agent for severe autoimmune dermatoses.
Optimized administration (e.g., pulsed i.v.) can mitigate toxicity concerns.
Further research and clinical adoption in dermatology are warranted.